Literature DB >> 27717277

Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome.

Maude Schneider1,2, Marco Armando1,3, Maria Pontillo3, Stefano Vicari3, Martin Debbané1,4,5, Frauke Schultze-Lutter6, Stephan Eliez1,7.   

Abstract

The 22q11.2 deletion syndrome (22q11DS) is characterized by high rates of psychotic symptoms and schizophrenia, making this condition a promising human model for studying risk factors for psychosis. We explored the predictive value of ultra high risk (UHR) criteria in a sample of patients with 22q11DS. We also examined the additional contribution of socio-demographic, clinical and cognitive variables to predict transition to psychosis within a mean interval of 32.5 ± 17.6 months after initial assessment. Eighty-nine participants with 22q11DS (age range: 8-30 years; mean 16.1 ± 4.7) were assessed using the Structured Interview for Psychosis-Risk Syndromes. Information on Axis I diagnoses, internalizing and externalizing symptoms, level of functioning and IQ was also collected. At baseline, 22 (24.7%) participants met UHR criteria. Compared to those without a UHR condition, they had a significantly lower functioning, more frequent anxiety disorders, and more severe psychopathology. Transition rate to psychosis was 27.3% in UHR and 4.5% in non-UHR participants. Cox regression analyses revealed that UHR status significantly predicted conversion to psychosis. Baseline level of functioning was the only other additional predictor. This is the first study investigating the predictive value of UHR criteria in 22q11DS. It indicates that the clinical path leading to psychosis is broadly comparable to that observed in other clinical high-risk samples. Nevertheless, the relatively high transition rate in non-UHR individuals suggests that other risk markers should be explored in this population. The role of low functioning as a predictor of transition to psychosis should also be investigated more in depth.
© 2016 World Psychiatric Association.

Entities:  

Keywords:  22q11.2 deletion syndrome; clinical high risk state; level of functioning; schizophrenia; transition to psychosis; ultra high risk criteria

Year:  2016        PMID: 27717277      PMCID: PMC5032509          DOI: 10.1002/wps.20347

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  44 in total

1.  Preliminary structure and predictive value of attenuated negative symptoms in 22q11.2 deletion syndrome.

Authors:  Maude Schneider; Martial Van der Linden; Bronwyn Glaser; Eleonora Rizzi; Sophie P Dahoun; Christine Hinard; Lucia Bartoloni; Stylianos E Antonarakis; Martin Debbané; Stephan Eliez
Journal:  Psychiatry Res       Date:  2012-02-27       Impact factor: 3.222

2.  Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: Findings from the BEAR and BEARS-kid studies.

Authors:  Benno G Schimmelmann; Chantal Michel; Alexandra Martz-Irngartinger; Caroline Linder; Frauke Schultze-Lutter
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

Review 3.  Ultra high-risk state for psychosis and non-transition: a systematic review.

Authors:  Andor E Simon; Eva Velthorst; Dorien H Nieman; Don Linszen; Daniel Umbricht; Lieuwe de Haan
Journal:  Schizophr Res       Date:  2011-07-23       Impact factor: 4.939

4.  Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning.

Authors:  Marco Armando; Paolo Girardi; Stefano Vicari; Deny Menghini; Maria Cristina Digilio; Maria Pontillo; Riccardo Saba; Luigi Mazzone; Ashleigh Lin; Claudia M Klier; Miriam R Schäfer; G Paul Amminger
Journal:  Schizophr Res       Date:  2012-05-23       Impact factor: 4.939

Review 5.  The psychosis high-risk state: a comprehensive state-of-the-art review.

Authors:  Paolo Fusar-Poli; Stefan Borgwardt; Andreas Bechdolf; Jean Addington; Anita Riecher-Rössler; Frauke Schultze-Lutter; Matcheri Keshavan; Stephen Wood; Stephan Ruhrmann; Larry J Seidman; Lucia Valmaggia; Tyrone Cannon; Eva Velthorst; Lieuwe De Haan; Barbara Cornblatt; Ilaria Bonoldi; Max Birchwood; Thomas McGlashan; William Carpenter; Patrick McGorry; Joachim Klosterkötter; Philip McGuire; Alison Yung
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

6.  EPA guidance on the early detection of clinical high risk states of psychoses.

Authors:  F Schultze-Lutter; C Michel; S J Schmidt; B G Schimmelmann; N P Maric; R K R Salokangas; A Riecher-Rössler; M van der Gaag; M Nordentoft; A Raballo; A Meneghelli; M Marshall; A Morrison; S Ruhrmann; J Klosterkötter
Journal:  Eur Psychiatry       Date:  2015-02-27       Impact factor: 5.361

7.  Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.

Authors:  Joel Stoddard; Tara Niendam; Robert Hendren; Cameron Carter; Tony J Simon
Journal:  Schizophr Res       Date:  2010-01-06       Impact factor: 4.939

8.  Premorbid adjustment and schizophrenia in individuals with 22q11.2 deletion syndrome.

Authors:  Tracy Yuen; Eva W C Chow; Candice K Silversides; Anne S Bassett
Journal:  Schizophr Res       Date:  2013-11-19       Impact factor: 4.939

9.  An examination of the relationship of anxiety and intelligence to adaptive functioning in children with chromosome 22q11.2 deletion syndrome.

Authors:  Kathleen Angkustsiri; Ingrid Leckliter; Nicole Tartaglia; Elliott A Beaton; Janice Enriquez; Tony J Simon
Journal:  J Dev Behav Pediatr       Date:  2012 Nov-Dec       Impact factor: 2.225

10.  Large recurrent microdeletions associated with schizophrenia.

Authors:  Hreinn Stefansson; Dan Rujescu; Sven Cichon; Olli P H Pietiläinen; Andres Ingason; Stacy Steinberg; Ragnheidur Fossdal; Engilbert Sigurdsson; Thordur Sigmundsson; Jacobine E Buizer-Voskamp; Thomas Hansen; Klaus D Jakobsen; Pierandrea Muglia; Clyde Francks; Paul M Matthews; Arnaldur Gylfason; Bjarni V Halldorsson; Daniel Gudbjartsson; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Bjornsson; Sigurborg Mattiasdottir; Thorarinn Blondal; Magnus Haraldsson; Brynja B Magnusdottir; Ina Giegling; Hans-Jürgen Möller; Annette Hartmann; Kevin V Shianna; Dongliang Ge; Anna C Need; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamarie Tuulio-Henriksson; Tiina Paunio; Timi Toulopoulou; Elvira Bramon; Marta Di Forti; Robin Murray; Mirella Ruggeri; Evangelos Vassos; Sarah Tosato; Muriel Walshe; Tao Li; Catalina Vasilescu; Thomas W Mühleisen; August G Wang; Henrik Ullum; Srdjan Djurovic; Ingrid Melle; Jes Olesen; Lambertus A Kiemeney; Barbara Franke; Chiara Sabatti; Nelson B Freimer; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Ole A Andreassen; Roel A Ophoff; Alexander Georgi; Marcella Rietschel; Thomas Werge; Hannes Petursson; David B Goldstein; Markus M Nöthen; Leena Peltonen; David A Collier; David St Clair; Kari Stefansson
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

View more
  21 in total

1.  Why ultra high risk criteria for psychosis prediction do not work well outside clinical samples and what to do about it.

Authors:  Paolo Fusar-Poli
Journal:  World Psychiatry       Date:  2017-06       Impact factor: 49.548

Review 2.  Understanding the pediatric psychiatric phenotype of 22q11.2 deletion syndrome.

Authors:  Ania M Fiksinski; Maude Schneider; Clodagh M Murphy; Marco Armando; Stefano Vicari; Jaume M Canyelles; Doron Gothelf; Stephan Eliez; Elemi J Breetvelt; Celso Arango; Jacob A S Vorstman
Journal:  Am J Med Genet A       Date:  2018-09-08       Impact factor: 2.802

3.  Developmental Trajectories of Cortical Thickness in Relation to Schizotypy During Adolescence.

Authors:  Mélodie Derome; Emiliana Tonini; Daniela Zöller; Marie Schaer; Stephan Eliez; Martin Debbané
Journal:  Schizophr Bull       Date:  2020-03-05       Impact factor: 9.306

Review 4.  Neural mechanisms underlying visual and auditory processing impairments in schizophrenia: insight into the etiology and implications for tailoring preventive and therapeutic interventions.

Authors:  Chuanjun Zhuo; Hongjun Tian; Tao Fang; Ranli Li; Yachen Li; Lingguang Kong; Ziyao Cai; Lidan Zheng; Xiaodong Lin; Ce Chen
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

5.  Coping Strategies Mediate the Effect of Stressful Life Events on Schizotypal Traits and Psychotic Symptoms in 22q11.2 Deletion Syndrome.

Authors:  Marco Armando; Corrado Sandini; Maelle Chambaz; Marie Schaer; Maude Schneider; Stephan Eliez
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

6.  Predictive validity of conversion from the clinical high risk syndrome to frank psychosis.

Authors:  Laura A Yoviene Sykes; Maria Ferrara; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Diana O Perkins; Daniel H Mathalon; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan; Kristen A Woodberry; Albert R Powers; Allison N Ponce; John D Cahill; Jessica M Pollard; Vinod H Srihari; Scott W Woods
Journal:  Schizophr Res       Date:  2019-12-19       Impact factor: 4.939

7.  Positive psychotic symptoms are associated with divergent developmental trajectories of hippocampal volume during late adolescence in patients with 22q11DS.

Authors:  Valentina Mancini; Corrado Sandini; Maria C Padula; Daniela Zöller; Maude Schneider; Marie Schaer; Stephan Eliez
Journal:  Mol Psychiatry       Date:  2019-06-04       Impact factor: 15.992

8.  Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.

Authors:  Omri Weisman; Yael Guri; Raquel E Gur; Donna M McDonald-McGinn; Monica E Calkins; Sunny X Tang; Beverly Emanuel; Elaine H Zackai; Stephan Eliez; Maude Schneider; Marie Schaer; Wendy R Kates; Kevin M Antshel; Wanda Fremont; Vandana Shashi; Stephen R Hooper; Marco Armando; Stefano Vicari; Maria Pontillo; Leila Kushan; Maria Jalbrzikowski; Carrie E Bearden; Joseph F Cubells; Opal Y Ousley; Elaine F Walker; Tony J Simon; Joel Stoddard; Tara A Niendam; Marianne B M van den Bree; Doron Gothelf
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

9.  Long-term effects of early treatment with SSRIs on cognition and brain development in individuals with 22q11.2 deletion syndrome.

Authors:  Valentina Mancini; Johanna Maeder; Karin Bortolin; Maude Schneider; Marie Schaer; Stephan Eliez
Journal:  Transl Psychiatry       Date:  2021-05-29       Impact factor: 6.222

10.  Inter-rater reliability of subthreshold psychotic symptoms in individuals with 22q11.2 deletion syndrome.

Authors:  Tyler M Moore; Deby Salzer; Doron Gothelf; Carrie E Bearden; Monica E Calkins; Wendy R Kates; Leila Kushan; Robert Sean Gallagher; Dafna Sofrin Frumer; Ronnie Weinberger; Donna M McDonald-McGinn; Raquel E Gur
Journal:  J Neurodev Disord       Date:  2021-06-14       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.